XML 38 R21.htm IDEA: XBRL DOCUMENT
v3.25.0.1

INCOME TAXES | 12 Months Ended
--- | ---
Dec. 28, 2024
Income Tax Disclosure [Abstract] |
INCOME TAXES | INCOME TAXES The components of income from operations before income taxes and the related provision for income taxes are presented below:
| Fiscal Year
| 2024 |  | 2023 |  | 2022
| (in thousands)
Income before income taxes: |  |  |  |  |
U.S. | $ | (290,308) |  |  | $ | 185,667 |  |  | $ | 280,075 |
Non-U.S. | 383,422 |  |  | 395,617 |  |  | 342,912 |
Total income before income taxes | $ | 93,114 |  |  | $ | 581,284 |  |  | $ | 622,987 |
Income tax provision (benefit): |  |  |  |  |
Current: |  |  |  |  |
Federal | $ | 36,349 |  |  | $ | 49,090 |  |  | $ | 75,052 |
Foreign | 86,493 |  |  | 85,356 |  |  | 68,644 |
State | 12,175 |  |  | 17,817 |  |  | 19,790 |
Total current | 135,017 |  |  | 152,263 |  |  | 163,486 |
Deferred: |  |  |  |  |
Federal | (50,555) |  |  | (42,987) |  |  | (27,230) |
Foreign | (6,922) |  |  | 779 |  |  | (1,134) |
State | (9,717) |  |  | (9,141) |  |  | (4,743) |
Total deferred | (67,194) |  |  | (51,349) |  |  | (33,107) |
Total provision for income taxes | $ | 67,823 |  |  | $ | 100,914 |  |  | $ | 130,379 |
Reconciliations of the statutory U.S. federal income tax rate to effective tax rates are as follows:
| Fiscal Year
| 2024 |  | 2023 |  | 2022
U.S. statutory income tax rate | 21.0 | % |  | 21.0 | % |  | 21.0 | %
Foreign tax rate differences | 11.1 |  |  | 1.5 |  |  | 0.4 |
State income taxes, net of federal tax benefit | (1.2) |  |  | 1.7 |  |  | 2.3 |
Non-deductible compensation | 5.2 |  |  | 0.8 |  |  | 0.9 |
Research tax credits and enhanced deductions | (29.3) |  |  | (5.0) |  |  | (3.8) |
Stock-based compensation | 2.6 |  |  | (0.1) |  |  | (1.4) |
Enacted tax rate changes | 3.0 |  |  | (0.1) |  |  | 0.4 |
Tax on unremitted earnings | 10.7 |  |  | 1.7 |  |  | 1.6 |
Impact of tax uncertainties | 0.6 |  |  | (0.3) |  |  | (1.3) |
Impact of acquisitions and restructuring | 1.3 |  |  | (4.2) |  |  | 2.0 |
Net operating loss deferred tax asset recognition, net of valuation allowance (NOL DTA) | (0.9) |  |  | 0.2 |  |  | (0.8) |
Global intangible low-taxed income | 6.3 |  |  | 1.5 |  |  | 0.8 |
Foreign-derived intangible income | (7.6) |  |  | (1.4) |  |  | (1.4) |
Goodwill Impairment | 48.5 |  |  | — |  |  | — |
Foreign Local Tax | 1.6 |  |  | 0.7 |  |  | 0.6 |
Other | (0.1) |  |  | (0.6) |  |  | (0.4) |
Effective income tax rate | 72.8 | % |  | 17.4 | % |  | 20.9 | %
The components of deferred tax assets and liabilities are as follows:
| December 28, 2024 |  | December 30, 2023
| (in thousands)
Deferred tax assets: |  |  |
Compensation | $ | 34,932 |  |  | $ | 30,167 |
Accruals and reserves | 17,523 |  |  | 19,121 |
Net operating loss and credit carryforwards | 348,228 |  |  | 379,959 |
Operating lease liability | 132,388 |  |  | 117,449 |
Capitalized R&D Expenditures | 46,247 |  |  | 35,673 |
Other | 25,133 |  |  | 12,190 |
Valuation allowance | (286,771) |  |  | (304,248) |
Total deferred tax assets | 317,680 |  |  | 290,311 |
Deferred tax liabilities: |  |  |
Goodwill and other intangibles | (198,103) |  |  | (231,020) |
Depreciation related | (41,481) |  |  | (57,791) |
Venture capital investments | (1,654) |  |  | (8,350) |
Tax on unremitted earnings | (11,622) |  |  | (25,080) |
Right-of-use assets | (113,631) |  |  | (102,620) |
Other | (15,970) |  |  | (16,520) |
Total deferred tax liabilities | (382,461) |  |  | (441,381) |
Net deferred taxes | $ | (64,781) |  |  | $ | (151,070) |
The Company has recognized its deferred tax assets on the belief that it is more likely than not that they will be realized. Exceptions primarily relate to deferred tax assets for net operating losses in Luxembourg, Sweden, state research and development tax credits, certain capital losses, and fixed assets in the U.K. and Ireland. A reconciliation of the Company’s beginning and ending valuation allowance are as follows:
| Fiscal Year
| 2024 |  | 2023 |  | 2022
Beginning balance | $ | 304,248 |  |  | $ | 294,753 |  |  | $ | 315,645 |
Additions (reductions) charged to income tax provision, net | 965 |  |  | 963 |  |  | 1,929 |
Reductions due to divestitures, restructuring | (1,877) |  |  | — |  |  | (5,337) |
Currency translation and other | (16,565) |  |  | 8,532 |  |  | (17,484) |
Ending balance | $ | 286,771 |  |  | $ | 304,248 |  |  | $ | 294,753 |
As of December 28, 2024, the Company had tax-effected deferred tax assets for net operating loss carryforwards of $311.7 million, as compared to $336.0 million as of December 30, 2023. Of this amount, $27.3 million are definite-lived and begin to expire in 2027, and the remainder of $284.4 million can be carried forward indefinitely. The Company has deferred tax assets for tax credit carryforwards of $36.1 million. The entire $36.1 million are definite-lived and begin to expire after 2039. Additionally, the Company records a benefit to operating income for research and development and other credits in Quebec, France, the Netherlands, and the U.K. related to its DSA facilities. A reconciliation of the Company’s beginning and ending unrecognized income tax benefits is as follows:
| Fiscal Year
| 2024 |  | 2023 |  | 2022
| (in thousands)
Beginning balance | $ | 22,702 |  |  | $ | 23,242 |  |  | $ | 32,592 |
Additions to tax positions for current year | 2,649 |  |  | 3,093 |  |  | 4,756 |
Additions to tax positions for prior years | 852 |  |  | 721 |  |  | 962 |
Reductions to tax positions for prior years | (801) |  |  | (4,058) |  |  | (1,420) |
Settlements | — |  |  | — |  |  | (10,514) |
Expiration of statute of limitations | (362) |  |  | (296) |  |  | (3,134) |
Ending balance | $ | 25,040 |  |  | $ | 22,702 |  |  | $ | 23,242 |
The $2.3 million increase in unrecognized income tax benefits during fiscal year 2024 as compared to the corresponding period in 2023 is primarily attributable to an additional year of Canadian Scientific Research and Experimental Development (SR&ED) credit additions, offset by favorable foreign exchange movement, as well as statute of limitations lapse on R&D credits. The amount of unrecognized income tax benefits that, if recognized, would favorably impact the effective tax rate was $22.0 million as of December 28, 2024 and $20.3 million as of December 30, 2023. It is reasonably possible as of December 28, 2024 that the liability for unrecognized tax benefits for the uncertain tax position will decrease by approximately $7.5 million over the next twelve-month period. The Company continues to recognize interest and penalties related to unrecognized income tax benefits in income tax expense. The total amount of cumulative accrued interest related to unrecognized income tax benefits as of December 28, 2024 and December 30, 2023 was $2.0 million and $1.3 million, respectively. Interest expense recorded as a component of income taxes was immaterial for all periods. There were no accrued penalties related to unrecognized income tax benefits as of December 28, 2024 or as of December 30, 2023. The Company conducts business in a number of tax jurisdictions. As a result, it is subject to tax audits on a regular basis including, but not limited to, such major jurisdictions as the U.S., the U.K., China, France, Germany, and Canada. With few exceptions, the Company is no longer subject to U.S. and international income tax examinations for years before 2020. The Company and certain of its subsidiaries have ongoing tax controversies in the U.S., Canada, France, China, Hungary, Israel, Ireland, Singapore, and India. The Company does not anticipate resolution of these audits will have a material impact on its consolidated financial statements. Prepaid income tax of $83.0 million and $59.7 million has been presented within Other current assets in the accompanying consolidated balance sheets as of December 28, 2024 and December 30, 2023, respectively. Accrued income taxes of $31.9 million and $38.8 million have been presented within Other current liabilities in the accompanying consolidated balance sheets as of December 28, 2024 and December 30, 2023, respectively.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration